Premetrexed combined with paclitaxel in NSCLC phase I-II

被引：0
|
作者：
Stathopoulos, George P. [1 ]
Dimitroulis, John [1 ]
Toubis, Michael [1 ]
Katis, Costas [1 ]
Karaindros, Dimitris [1 ]
Stathopoulos, John [1 ]
Koutandos, John [1 ]
机构：
[1] Errikos Dunant Hosp, Solca Grp, Oncol Clin A, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [1] A phase I-II study with carboplatin (C) and weekly paclitaxel (P) in advanced NSCLC
    Fabi, A
    Barduagni, M
    De Marco, S
    De Marinis, F
    Cortesi, E
    Foggi, CM
    Chiapparino, E
    Gareri, R
    Venturoli, AL
    Cognetti, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S264
  • [2] Paclitaxel and Carboplatin in combination with Gemcitabine (PCG): A phase I-II trial in non-small cell lung cancer (NSCLC)
    Favaretto, A
    Paccagnella, A
    Tumolo, S
    Barbieri, F
    Ceresoli, G
    Gulisano, M
    Oniga, F
    Bearz, A
    Fiorentino, MV
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [3] Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial
    Stathopoulos, George P.
    Dimitroulis, John
    Toubis, Michael
    Katis, Costas
    Karaindros, Dimitris
    Stathopoulos, John
    Koutandos, John
    LUNG CANCER, 2007, 57 (01) : 66 - 71
  • [4] Combined and modulated adjuvant therapy in prostate carcinoma: a phase I-II trial
    Nuzzo, M.
    Frascino, V.
    Alitto, A. R.
    Mattiucci, G.
    Fionda, B.
    Vernaleone, M.
    Catucci, F.
    Bassi, P.
    Macchia, G.
    Deodato, F.
    Siepe, G.
    Ntreta, M.
    Morganti, A. G.
    Cammelli, S.
    Arcelli, A.
    Bertini, F.
    Ippolito, E.
    Frezza, G.
    Mantini, G.
    Valentini, V.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S633 - S633
  • [5] PHASE I-II STUDY WITH INTRAVENOUS PACLITAXEL AND ORAL CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC CARCINOMA OF THE BLADDER
    Verze, P.
    Di Lorenzo, G.
    Imbimbo, C.
    Creta, M.
    Arcaniolo, D.
    Forchia, F.
    Mirone, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 256 - 256
  • [6] Phase I-II dose escalation study of celecoxib (C) in combination with paclitaxel (T) and carboplatinum (CP) in non small cell lung cancer (NSCLC).
    Gupta, V
    Weigand, T
    Rangineni, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 693S - 693S
  • [7] Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer
    Bourgeois, Hugues
    Ferru, Aurelie
    Lortholary, Alain
    Delozier, Thierry
    Boisdron-Celle, Michelle
    Abadie-Lacourtoisie, Sophie
    Joly, Florence
    Chieze, Stephanie
    Chabrun, Virginie
    Gamelin, Erick
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (03): : 267 - 275
  • [8] Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study
    Stier, S
    Koll, C
    Neuhaus, T
    Fronhoffs, S
    Forkert, R
    Tuohimaa, A
    Vetter, H
    Ko, Y
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1115 - 1121
  • [9] Paclitaxel and carboplatin with concurrent radiotherapy in advanced cancer of the head and neck.: A phase I-II trial
    Jaén, A
    Martos, M
    González, E
    Medina, B
    Sánchez, P
    Cabrero, A
    Capllonch, M
    Fernández, M
    Casanova, MA
    Lozano, A
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 1035 - 1041
  • [10] A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer
    Bolis, G
    Scarfone, G
    Zanaboni, F
    Villa, A
    Presti, M
    Melpignano, M
    Ferraris, C
    Tateo, S
    Guarnerio, P
    Gentile, A
    Parazzini, F
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 592 - 595
12345